The Placebo Effect Mechanisms and Methodology (R01) | Apply Online

Opportunity Summary:

The grant opportunity titled "The Placebo Effect Mechanisms and Methodology (R01)" (Funding Opportunity Number RFA-DA-12-003) was a National Institutes of Health (NIH) discretionary funding announcement designed to support research that digs into how placebo effects actually work and how they can be better handled in both clinical trials and real-world care. Using the standard NIH Research Project Grant (R01) mechanism, the program aimed to stimulate basic science and methodological research focused on identifying the biological pathways that contribute to placebo responses, along with improving the ability of researchers and clinicians to detect, interpret, and potentially strengthen the therapeutic benefit that placebo-related mechanisms can produce. In practical terms, the opportunity was framed around moving beyond the idea of placebo as merely a nuisance variable in trials, and instead treating placebo effects as measurable, biologically grounded phenomena that can be studied, predicted, and ethically leveraged to improve outcomes.

From a scientific standpoint, the central purpose was to encourage studies that clarify the underlying mechanisms of placebo effects, which can involve neurobiological signaling, brain-body communication, learning and conditioning processes, expectation and reward pathways, and other psychophysiological processes that influence symptoms and recovery. The FOA emphasized the need for mechanistic insight rather than just documenting that placebo effects exist. It also highlighted methodology, meaning it supported work that improves how placebo effects are recognized and measured in research settings, and how trial designs might be refined to separate placebo responses from treatment-specific effects or to intentionally account for placebo-related therapeutic components. This includes better approaches to study design, outcome measurement, blinding, assessment of expectancy, and other factors that shape placebo responding and can bias or mask true treatment effects if not properly understood.

Administratively, this was a grant (not a contract) offered under the NIH umbrella, with activity in the education and health research space, and tied to multiple CFDA program areas: 93.213 (Research and Training in Complementary and Integrative Health), 93.273 (Alcohol Research Programs), and 93.279 (Drug Abuse and Addiction Research Programs). That combination signals that NIH saw placebo mechanisms as broadly relevant across clinical domains, including but not limited to integrative health contexts and substance use research, where expectancy and context effects can be especially influential in symptom perception, craving, pain, stress, and treatment engagement. The program did not require cost sharing or matching, which is typical for many NIH research grants and reduces barriers for applicants that might not have external funds to contribute.

Eligibility for the opportunity was broad and included a wide range of U.S. and non-U.S. organizations. Eligible applicants included for-profit organizations (including small businesses), nonprofits with and without 501(c)(3) status (including faith-based and community-based organizations), public and private institutions of higher education, and numerous government entities such as state governments, county governments, special district governments, and city or township governments. The eligibility list also explicitly included tribal entities (both federally recognized and other than federally recognized), tribally controlled colleges and universities (TCCUs), and designated-serving institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, as well as U.S. territories or possessions. Foreign (non-U.S.) organizations and regional organizations were also identified as eligible, reflecting NIH interest in high-quality placebo mechanism research regardless of geography, provided the work aligns with NIH requirements and scientific priorities.

In terms of timing, the announcement was posted and created on February 17, 2011, with an original and current closing date of May 24, 2011. The opportunity was later archived on June 24, 2011, meaning it was no longer open for applications after that cycle. Applicants seeking the full details, including specific scientific areas of interest, application instructions, review criteria, and any special requirements, were directed to the NIH grants page for the FOA (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-12-003.html). For technical access issues related to the electronic announcement, NIH provided support via the NIH Office of Extramural Research (OER) webmaster contact (FBOWebmaster@OD.NIH.GOV).

Overall, this FOA can be summarized as an NIH effort to fund rigorous R01-level research that treats the placebo effect as a legitimate target of biomedical and behavioral science, with the dual goal of (1) clarifying the biological and psychosocial mechanisms that generate placebo responses and (2) improving clinical research methods so placebo-related influences are better understood, more accurately measured, and potentially used to enhance therapeutic benefit in ethical and scientifically sound ways.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Childhood Cancer Survivor Study (CCSS)(Limited Competition U24)

Previous opportunity: The Placebo Effect Mechanisms and Methodology (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 12 003

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 12 003) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 12 003", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.